nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminocaproic Acid—AOX1—Methotrexate—ankylosing spondylitis	0.589	1	CbGbCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—CREG1—ankylosing spondylitis	0.025	0.132	CbGpPWpGaD
Aminocaproic Acid—PLG—Orphan transporters—ANO6—ankylosing spondylitis	0.0191	0.101	CbGpPWpGaD
Aminocaproic Acid—PLAT—Orphan transporters—ANO6—ankylosing spondylitis	0.0191	0.101	CbGpPWpGaD
Aminocaproic Acid—PLAT—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.0117	0.0616	CbGpPWpGaD
Aminocaproic Acid—PLAT—Beta2 integrin cell surface interactions—CD40LG—ankylosing spondylitis	0.0109	0.0573	CbGpPWpGaD
Aminocaproic Acid—PLG—Activation of Matrix Metalloproteinases—MMP3—ankylosing spondylitis	0.0107	0.0563	CbGpPWpGaD
Aminocaproic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—ankylosing spondylitis	0.00862	0.0453	CbGpPWpGaD
Aminocaproic Acid—Intracranial pressure increased—Prednisolone—ankylosing spondylitis	0.00657	0.0297	CcSEcCtD
Aminocaproic Acid—Intracranial pressure increased—Triamcinolone—ankylosing spondylitis	0.00604	0.0273	CcSEcCtD
Aminocaproic Acid—Intracranial pressure increased—Methylprednisolone—ankylosing spondylitis	0.00603	0.0273	CcSEcCtD
Aminocaproic Acid—PLAT—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.00583	0.0307	CbGpPWpGaD
Aminocaproic Acid—PLG—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.00583	0.0307	CbGpPWpGaD
Aminocaproic Acid—PLG—p75(NTR)-mediated signaling—MMP3—ankylosing spondylitis	0.00579	0.0305	CbGpPWpGaD
Aminocaproic Acid—Intracranial pressure increased—Dexamethasone—ankylosing spondylitis	0.00548	0.0248	CcSEcCtD
Aminocaproic Acid—Intracranial pressure increased—Betamethasone—ankylosing spondylitis	0.00548	0.0248	CcSEcCtD
Aminocaproic Acid—Intracranial pressure increased—Prednisone—ankylosing spondylitis	0.00477	0.0216	CcSEcCtD
Aminocaproic Acid—PLAT—Folate Metabolism—CRP—ankylosing spondylitis	0.00474	0.0249	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—CRP—ankylosing spondylitis	0.00474	0.0249	CbGpPWpGaD
Aminocaproic Acid—PLG—Degradation of the extracellular matrix—MMP3—ankylosing spondylitis	0.00473	0.0248	CbGpPWpGaD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00467	0.0246	CbGpPWpGaD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00467	0.0246	CbGpPWpGaD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—IL1A—ankylosing spondylitis	0.00391	0.0206	CbGpPWpGaD
Aminocaproic Acid—Myopathy—Prednisolone—ankylosing spondylitis	0.00391	0.0177	CcSEcCtD
Aminocaproic Acid—PLAT—amb2 Integrin signaling—TNF—ankylosing spondylitis	0.00383	0.0202	CbGpPWpGaD
Aminocaproic Acid—PLG—amb2 Integrin signaling—TNF—ankylosing spondylitis	0.00383	0.0202	CbGpPWpGaD
Aminocaproic Acid—PLAT—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.00377	0.0198	CbGpPWpGaD
Aminocaproic Acid—PLG—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.00377	0.0198	CbGpPWpGaD
Aminocaproic Acid—Myopathy—Triamcinolone—ankylosing spondylitis	0.0036	0.0163	CcSEcCtD
Aminocaproic Acid—Myopathy—Methylprednisolone—ankylosing spondylitis	0.00359	0.0162	CcSEcCtD
Aminocaproic Acid—Myopathy—Dexamethasone—ankylosing spondylitis	0.00327	0.0148	CcSEcCtD
Aminocaproic Acid—Myopathy—Betamethasone—ankylosing spondylitis	0.00327	0.0148	CcSEcCtD
Aminocaproic Acid—Necrosis—Methylprednisolone—ankylosing spondylitis	0.00321	0.0145	CcSEcCtD
Aminocaproic Acid—Necrosis—Dexamethasone—ankylosing spondylitis	0.00292	0.0132	CcSEcCtD
Aminocaproic Acid—Necrosis—Betamethasone—ankylosing spondylitis	0.00292	0.0132	CcSEcCtD
Aminocaproic Acid—Myopathy—Prednisone—ankylosing spondylitis	0.00284	0.0129	CcSEcCtD
Aminocaproic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—TNF—ankylosing spondylitis	0.00268	0.0141	CbGpPWpGaD
Aminocaproic Acid—PLAT—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00264	0.0139	CbGpPWpGaD
Aminocaproic Acid—PLG—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00264	0.0139	CbGpPWpGaD
Aminocaproic Acid—Necrosis—Prednisone—ankylosing spondylitis	0.00254	0.0115	CcSEcCtD
Aminocaproic Acid—Delirium—Prednisone—ankylosing spondylitis	0.00232	0.0105	CcSEcCtD
Aminocaproic Acid—PLG—Folate Metabolism—TNF—ankylosing spondylitis	0.00215	0.0113	CbGpPWpGaD
Aminocaproic Acid—PLAT—Folate Metabolism—TNF—ankylosing spondylitis	0.00215	0.0113	CbGpPWpGaD
Aminocaproic Acid—Necrosis—Methotrexate—ankylosing spondylitis	0.00212	0.0096	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.00206	0.00931	CcSEcCtD
Aminocaproic Acid—PLG—Extracellular matrix organization—MMP3—ankylosing spondylitis	0.00198	0.0104	CbGpPWpGaD
Aminocaproic Acid—PLG—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.0019	0.00997	CbGpPWpGaD
Aminocaproic Acid—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.00189	0.00856	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.00189	0.00854	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Prednisolone—ankylosing spondylitis	0.00176	0.00795	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.00172	0.00777	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.00172	0.00777	CcSEcCtD
Aminocaproic Acid—PLAT—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.00171	0.00897	CbGpPWpGaD
Aminocaproic Acid—PLG—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.00171	0.00897	CbGpPWpGaD
Aminocaproic Acid—Pulmonary embolism—Methotrexate—ankylosing spondylitis	0.00167	0.00754	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.00162	0.00731	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.00161	0.00729	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Betamethasone—ankylosing spondylitis	0.00147	0.00663	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.00147	0.00663	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—ANTXR2—ankylosing spondylitis	0.00145	0.00761	CbGpPWpGaD
Aminocaproic Acid—Bradycardia—Prednisolone—ankylosing spondylitis	0.0014	0.00635	CcSEcCtD
Aminocaproic Acid—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00129	0.00584	CcSEcCtD
Aminocaproic Acid—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00129	0.00582	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Prednisone—ankylosing spondylitis	0.00128	0.00577	CcSEcCtD
Aminocaproic Acid—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00126	0.00569	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.00125	0.00565	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.00123	0.00558	CcSEcCtD
Aminocaproic Acid—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00117	0.00529	CcSEcCtD
Aminocaproic Acid—Bradycardia—Betamethasone—ankylosing spondylitis	0.00117	0.00529	CcSEcCtD
Aminocaproic Acid—Hallucination—Dexamethasone—ankylosing spondylitis	0.00114	0.00517	CcSEcCtD
Aminocaproic Acid—Hallucination—Betamethasone—ankylosing spondylitis	0.00114	0.00517	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00111	0.00503	CcSEcCtD
Aminocaproic Acid—Malaise—Prednisolone—ankylosing spondylitis	0.00108	0.00489	CcSEcCtD
Aminocaproic Acid—Syncope—Prednisolone—ankylosing spondylitis	0.00108	0.00487	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00105	0.00477	CcSEcCtD
Aminocaproic Acid—Convulsion—Prednisolone—ankylosing spondylitis	0.00104	0.0047	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00102	0.00463	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00102	0.00462	CcSEcCtD
Aminocaproic Acid—Bradycardia—Prednisone—ankylosing spondylitis	0.00102	0.00461	CcSEcCtD
Aminocaproic Acid—Discomfort—Prednisolone—ankylosing spondylitis	0.00101	0.00456	CcSEcCtD
Aminocaproic Acid—Hallucination—Prednisone—ankylosing spondylitis	0.000996	0.00451	CcSEcCtD
Aminocaproic Acid—Malaise—Triamcinolone—ankylosing spondylitis	0.000995	0.0045	CcSEcCtD
Aminocaproic Acid—Malaise—Methylprednisolone—ankylosing spondylitis	0.000993	0.00449	CcSEcCtD
Aminocaproic Acid—Syncope—Triamcinolone—ankylosing spondylitis	0.000989	0.00447	CcSEcCtD
Aminocaproic Acid—Syncope—Methylprednisolone—ankylosing spondylitis	0.000987	0.00446	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000979	0.00443	CcSEcCtD
Aminocaproic Acid—Oedema—Prednisolone—ankylosing spondylitis	0.000979	0.00443	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00097	0.00439	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000967	0.00438	CcSEcCtD
Aminocaproic Acid—Shock—Prednisolone—ankylosing spondylitis	0.000963	0.00436	CcSEcCtD
Aminocaproic Acid—Convulsion—Triamcinolone—ankylosing spondylitis	0.000956	0.00432	CcSEcCtD
Aminocaproic Acid—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000954	0.00431	CcSEcCtD
Aminocaproic Acid—Myalgia—Triamcinolone—ankylosing spondylitis	0.000939	0.00425	CcSEcCtD
Aminocaproic Acid—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000937	0.00424	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000929	0.0042	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000929	0.0042	CcSEcCtD
Aminocaproic Acid—Discomfort—Triamcinolone—ankylosing spondylitis	0.000928	0.0042	CcSEcCtD
Aminocaproic Acid—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000926	0.00419	CcSEcCtD
Aminocaproic Acid—Renal failure—Methotrexate—ankylosing spondylitis	0.000916	0.00415	CcSEcCtD
Aminocaproic Acid—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000906	0.0041	CcSEcCtD
Aminocaproic Acid—Malaise—Betamethasone—ankylosing spondylitis	0.000903	0.00408	CcSEcCtD
Aminocaproic Acid—Malaise—Dexamethasone—ankylosing spondylitis	0.000903	0.00408	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.0009	0.00407	CcSEcCtD
Aminocaproic Acid—Oedema—Triamcinolone—ankylosing spondylitis	0.0009	0.00407	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000898	0.00406	CcSEcCtD
Aminocaproic Acid—Syncope—Dexamethasone—ankylosing spondylitis	0.000898	0.00406	CcSEcCtD
Aminocaproic Acid—Syncope—Betamethasone—ankylosing spondylitis	0.000898	0.00406	CcSEcCtD
Aminocaproic Acid—Shock—Triamcinolone—ankylosing spondylitis	0.000886	0.00401	CcSEcCtD
Aminocaproic Acid—Shock—Methylprednisolone—ankylosing spondylitis	0.000884	0.004	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00088	0.00398	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00088	0.00398	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00087	0.00394	CcSEcCtD
Aminocaproic Acid—Convulsion—Dexamethasone—ankylosing spondylitis	0.000867	0.00392	CcSEcCtD
Aminocaproic Acid—Convulsion—Betamethasone—ankylosing spondylitis	0.000867	0.00392	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—B3GNT2—ankylosing spondylitis	0.000853	0.00448	CbGpPWpGaD
Aminocaproic Acid—Myalgia—Betamethasone—ankylosing spondylitis	0.000852	0.00385	CcSEcCtD
Aminocaproic Acid—Myalgia—Dexamethasone—ankylosing spondylitis	0.000852	0.00385	CcSEcCtD
Aminocaproic Acid—Discomfort—Dexamethasone—ankylosing spondylitis	0.000842	0.00381	CcSEcCtD
Aminocaproic Acid—Discomfort—Betamethasone—ankylosing spondylitis	0.000842	0.00381	CcSEcCtD
Aminocaproic Acid—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000839	0.0038	CcSEcCtD
Aminocaproic Acid—Pain—Prednisolone—ankylosing spondylitis	0.000837	0.00379	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00082	0.00371	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000818	0.0037	CcSEcCtD
Aminocaproic Acid—Oedema—Dexamethasone—ankylosing spondylitis	0.000817	0.0037	CcSEcCtD
Aminocaproic Acid—Oedema—Betamethasone—ankylosing spondylitis	0.000817	0.0037	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000817	0.0037	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000817	0.0037	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000809	0.00366	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000807	0.00365	CcSEcCtD
Aminocaproic Acid—Shock—Dexamethasone—ankylosing spondylitis	0.000804	0.00364	CcSEcCtD
Aminocaproic Acid—Shock—Betamethasone—ankylosing spondylitis	0.000804	0.00364	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000803	0.00363	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.0008	0.00362	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.0008	0.00362	CcSEcCtD
Aminocaproic Acid—Malaise—Prednisone—ankylosing spondylitis	0.000786	0.00356	CcSEcCtD
Aminocaproic Acid—Syncope—Prednisone—ankylosing spondylitis	0.000782	0.00354	CcSEcCtD
Aminocaproic Acid—Tinnitus—Methotrexate—ankylosing spondylitis	0.00078	0.00353	CcSEcCtD
Aminocaproic Acid—Pain—Triamcinolone—ankylosing spondylitis	0.00077	0.00348	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000766	0.00347	CcSEcCtD
Aminocaproic Acid—Hypotension—Dexamethasone—ankylosing spondylitis	0.000763	0.00345	CcSEcCtD
Aminocaproic Acid—Hypotension—Betamethasone—ankylosing spondylitis	0.000763	0.00345	CcSEcCtD
Aminocaproic Acid—Convulsion—Prednisone—ankylosing spondylitis	0.000755	0.00342	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000744	0.00337	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000744	0.00337	CcSEcCtD
Aminocaproic Acid—Myalgia—Prednisone—ankylosing spondylitis	0.000742	0.00336	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000742	0.00336	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00074	0.00335	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000735	0.00332	CcSEcCtD
Aminocaproic Acid—Discomfort—Prednisone—ankylosing spondylitis	0.000733	0.00332	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000721	0.00326	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—B3GNT2—ankylosing spondylitis	0.000714	0.00376	CbGpPWpGaD
Aminocaproic Acid—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000711	0.00322	CcSEcCtD
Aminocaproic Acid—Oedema—Prednisone—ankylosing spondylitis	0.000711	0.00322	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00071	0.00321	CcSEcCtD
Aminocaproic Acid—Shock—Prednisone—ankylosing spondylitis	0.0007	0.00317	CcSEcCtD
Aminocaproic Acid—Pain—Betamethasone—ankylosing spondylitis	0.000699	0.00316	CcSEcCtD
Aminocaproic Acid—Pain—Dexamethasone—ankylosing spondylitis	0.000699	0.00316	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000676	0.00306	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000673	0.00304	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000673	0.00304	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000668	0.00302	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000668	0.00302	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000663	0.003	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000662	0.00299	CcSEcCtD
Aminocaproic Acid—Malaise—Methotrexate—ankylosing spondylitis	0.000657	0.00297	CcSEcCtD
Aminocaproic Acid—Leukopenia—Methotrexate—ankylosing spondylitis	0.000652	0.00295	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000648	0.00293	CcSEcCtD
Aminocaproic Acid—Dizziness—Prednisolone—ankylosing spondylitis	0.000647	0.00293	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000646	0.00292	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000646	0.00292	CcSEcCtD
Aminocaproic Acid—Pruritus—Triamcinolone—ankylosing spondylitis	0.000637	0.00288	CcSEcCtD
Aminocaproic Acid—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000636	0.00287	CcSEcCtD
Aminocaproic Acid—Convulsion—Methotrexate—ankylosing spondylitis	0.000631	0.00286	CcSEcCtD
Aminocaproic Acid—Myalgia—Methotrexate—ankylosing spondylitis	0.00062	0.00281	CcSEcCtD
Aminocaproic Acid—Rash—Prednisolone—ankylosing spondylitis	0.000617	0.00279	CcSEcCtD
Aminocaproic Acid—Dermatitis—Prednisolone—ankylosing spondylitis	0.000617	0.00279	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000615	0.00278	CcSEcCtD
Aminocaproic Acid—Headache—Prednisolone—ankylosing spondylitis	0.000613	0.00277	CcSEcCtD
Aminocaproic Acid—Discomfort—Methotrexate—ankylosing spondylitis	0.000613	0.00277	CcSEcCtD
Aminocaproic Acid—Confusional state—Methotrexate—ankylosing spondylitis	0.0006	0.00271	CcSEcCtD
Aminocaproic Acid—Dizziness—Triamcinolone—ankylosing spondylitis	0.000595	0.00269	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000595	0.00269	CcSEcCtD
Aminocaproic Acid—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000594	0.00269	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000586	0.00265	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000582	0.00263	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000582	0.00263	CcSEcCtD
Aminocaproic Acid—Nausea—Prednisolone—ankylosing spondylitis	0.000582	0.00263	CcSEcCtD
Aminocaproic Acid—Pruritus—Dexamethasone—ankylosing spondylitis	0.000578	0.00261	CcSEcCtD
Aminocaproic Acid—Pruritus—Betamethasone—ankylosing spondylitis	0.000578	0.00261	CcSEcCtD
Aminocaproic Acid—Vomiting—Triamcinolone—ankylosing spondylitis	0.000572	0.00259	CcSEcCtD
Aminocaproic Acid—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000571	0.00258	CcSEcCtD
Aminocaproic Acid—Rash—Triamcinolone—ankylosing spondylitis	0.000568	0.00257	CcSEcCtD
Aminocaproic Acid—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000567	0.00257	CcSEcCtD
Aminocaproic Acid—Rash—Methylprednisolone—ankylosing spondylitis	0.000566	0.00256	CcSEcCtD
Aminocaproic Acid—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000566	0.00256	CcSEcCtD
Aminocaproic Acid—Headache—Triamcinolone—ankylosing spondylitis	0.000564	0.00255	CcSEcCtD
Aminocaproic Acid—Headache—Methylprednisolone—ankylosing spondylitis	0.000563	0.00255	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Prednisone—ankylosing spondylitis	0.000562	0.00254	CcSEcCtD
Aminocaproic Acid—PLG—Signaling Pathways—PTGER4—ankylosing spondylitis	0.00056	0.00295	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PTGER4—ankylosing spondylitis	0.00056	0.00295	CbGpPWpGaD
Aminocaproic Acid—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000559	0.00253	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000559	0.00253	CcSEcCtD
Aminocaproic Acid—Hypotension—Methotrexate—ankylosing spondylitis	0.000556	0.00251	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000542	0.00245	CcSEcCtD
Aminocaproic Acid—Dizziness—Dexamethasone—ankylosing spondylitis	0.00054	0.00244	CcSEcCtD
Aminocaproic Acid—Dizziness—Betamethasone—ankylosing spondylitis	0.00054	0.00244	CcSEcCtD
Aminocaproic Acid—Nausea—Triamcinolone—ankylosing spondylitis	0.000535	0.00242	CcSEcCtD
Aminocaproic Acid—Nausea—Methylprednisolone—ankylosing spondylitis	0.000534	0.00241	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00053	0.0024	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000524	0.00237	CcSEcCtD
Aminocaproic Acid—Vomiting—Dexamethasone—ankylosing spondylitis	0.000519	0.00235	CcSEcCtD
Aminocaproic Acid—Vomiting—Betamethasone—ankylosing spondylitis	0.000519	0.00235	CcSEcCtD
Aminocaproic Acid—Rash—Dexamethasone—ankylosing spondylitis	0.000515	0.00233	CcSEcCtD
Aminocaproic Acid—Rash—Betamethasone—ankylosing spondylitis	0.000515	0.00233	CcSEcCtD
Aminocaproic Acid—Dermatitis—Betamethasone—ankylosing spondylitis	0.000515	0.00233	CcSEcCtD
Aminocaproic Acid—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000515	0.00233	CcSEcCtD
Aminocaproic Acid—Headache—Dexamethasone—ankylosing spondylitis	0.000512	0.00231	CcSEcCtD
Aminocaproic Acid—Headache—Betamethasone—ankylosing spondylitis	0.000512	0.00231	CcSEcCtD
Aminocaproic Acid—Pain—Methotrexate—ankylosing spondylitis	0.000508	0.0023	CcSEcCtD
Aminocaproic Acid—Pruritus—Prednisone—ankylosing spondylitis	0.000503	0.00228	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00049	0.00222	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Prednisone—ankylosing spondylitis	0.000487	0.0022	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000486	0.0022	CcSEcCtD
Aminocaproic Acid—Nausea—Dexamethasone—ankylosing spondylitis	0.000485	0.00219	CcSEcCtD
Aminocaproic Acid—Nausea—Betamethasone—ankylosing spondylitis	0.000485	0.00219	CcSEcCtD
Aminocaproic Acid—Dizziness—Prednisone—ankylosing spondylitis	0.00047	0.00213	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00047	0.00213	CcSEcCtD
Aminocaproic Acid—Vomiting—Prednisone—ankylosing spondylitis	0.000452	0.00205	CcSEcCtD
Aminocaproic Acid—Rash—Prednisone—ankylosing spondylitis	0.000449	0.00203	CcSEcCtD
Aminocaproic Acid—Dermatitis—Prednisone—ankylosing spondylitis	0.000448	0.00203	CcSEcCtD
Aminocaproic Acid—Headache—Prednisone—ankylosing spondylitis	0.000446	0.00202	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000438	0.00198	CcSEcCtD
Aminocaproic Acid—Nausea—Prednisone—ankylosing spondylitis	0.000423	0.00191	CcSEcCtD
Aminocaproic Acid—Pruritus—Methotrexate—ankylosing spondylitis	0.000421	0.0019	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000407	0.00184	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling Pathways—MMP3—ankylosing spondylitis	0.000399	0.0021	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MMP3—ankylosing spondylitis	0.000399	0.0021	CbGpPWpGaD
Aminocaproic Acid—Dizziness—Methotrexate—ankylosing spondylitis	0.000393	0.00178	CcSEcCtD
Aminocaproic Acid—Vomiting—Methotrexate—ankylosing spondylitis	0.000378	0.00171	CcSEcCtD
Aminocaproic Acid—Rash—Methotrexate—ankylosing spondylitis	0.000375	0.0017	CcSEcCtD
Aminocaproic Acid—Dermatitis—Methotrexate—ankylosing spondylitis	0.000375	0.00169	CcSEcCtD
Aminocaproic Acid—Headache—Methotrexate—ankylosing spondylitis	0.000372	0.00168	CcSEcCtD
Aminocaproic Acid—Nausea—Methotrexate—ankylosing spondylitis	0.000353	0.0016	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—HLA-A—ankylosing spondylitis	0.000345	0.00181	CbGpPWpGaD
